Covington-Led AstraZeneca To Buy Belgian Biz For Up To $1B
British-Swedish pharmaceutical giant AstraZeneca PLC said Monday that it has agreed to buy cancer immunotherapy business EsoBiotec in a deal worth up to $1 billion in cash to develop its capabilities...To view the full article, register now.
Already a subscriber? Click here to view full article